Literature DB >> 11067904

Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma.

K L Denzler1, S C Farmer, J R Crosby, M Borchers, G Cieslewicz, K A Larson, S Cormier-Regard, N A Lee, J J Lee.   

Abstract

The relationship between eosinophils and the development of Ag-induced pulmonary pathologies, including airway hyper-responsiveness, was investigated using mice deficient for the secondary granule component, major basic protein-1 (mMBP-1). The loss of mMBP-1 had no effect on OVA-induced airway histopathologies or inflammatory cell recruitment. Lung function measurements of knockout mice demonstrated a generalized hyporeactivity to methacholine-induced airflow changes (relative to wild type); however, this baseline phenotype was observable only with methacholine; no relative airflow changes were observed in response to another nonspecific stimulus (serotonin). Moreover, OVA sensitization/aerosol challenge of wild-type and mMBP-1(-/-) mice resulted in identical dose-response changes to either methacholine or serotonin. Thus, the airway hyper-responsiveness in murine models of asthma occurs in the absence of mMBP-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067904     DOI: 10.4049/jimmunol.165.10.5509

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

2.  Eosinophils, but not eosinophil peroxidase or major basic protein, are important for host protection in experimental Brugia pahangi infection.

Authors:  Thirumalai Ramalingam; Patricia Porte; James Lee; T V Rajan
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation.

Authors:  Elizabeth A Jacobsen; Sergei I Ochkur; Alfred D Doyle; William E LeSuer; Wen Li; Cheryl A Protheroe; Dana Colbert; Katie R Zellner; HuaHao H Shen; Charles G Irvin; James J Lee; Nancy A Lee
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

4.  Frontline Science: Eosinophil-deficient MBP-1 and EPX double-knockout mice link pulmonary remodeling and airway dysfunction with type 2 inflammation.

Authors:  Sergei I Ochkur; Alfred D Doyle; Elizabeth A Jacobsen; William E LeSuer; Wen Li; Cheryl A Protheroe; Katie R Zellner; Dana Colbert; HuaHao H Shen; Charlie G Irvin; James J Lee; Nancy A Lee
Journal:  J Leukoc Biol       Date:  2017-05-17       Impact factor: 4.962

Review 5.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 6.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

7.  Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways.

Authors:  Caroline M Percopo; Julia O Krumholz; Elizabeth R Fischer; Laura S Kraemer; Michelle Ma; Karen Laky; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2018-10-04       Impact factor: 4.962

8.  Eosinophil survival and apoptosis in health and disease.

Authors:  Yong Mean Park; Bruce S Bochner
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

9.  Distribution of major basic protein on human airway following in vitro eosinophil incubation.

Authors:  Ailing Xue; John Wang; Gary C Sieck; Mark E Wylam
Journal:  Mediators Inflamm       Date:  2010-03-22       Impact factor: 4.711

10.  Activated mouse eosinophils protect against lethal respiratory virus infection.

Authors:  Caroline M Percopo; Kimberly D Dyer; Sergei I Ochkur; Janice L Luo; Elizabeth R Fischer; James J Lee; Nancy A Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.